Zobrazeno 1 - 3
of 3
pro vyhledávání: '"gk-2 compound"'
Autor:
E. S. Pekeldina, I. A. Miroshkina, A. V. Sorokina, N. M. Sazonova, M. B. Vititnova, S. A. Kryzhanovskiy
Publikováno v:
Фармакокинетика и Фармакодинамика, Vol 0, Iss 4, Pp 24-28 (2022)
Earlier, in experiments in vitro and in vivo, it was shown that the TrkA receptor agonist compound GK-2, which was a low molecular weight NGF mimetic, had pronounced angiogenic and antiischemic activity. However, it remained unclear whether this acti
Externí odkaz:
https://doaj.org/article/810babfea0bf42b09d59bb669ea6d274
Autor:
E. S. Pekeldina, E. O. Ionova, I. A. Mirochkina, A. V. Sorokina, V. N. Stolyaruk, I. B. Tsorin, T. A. Gudacheva, S. A. Kryzhanovskii
Publikováno v:
Фармакокинетика и Фармакодинамика, Vol 0, Iss 2, Pp 16-21 (2018)
Resume. Relevance. One of the actual problems facing modern medical science is the study of mechanisms and the search for effective ways to activate tissue neovascularization. A possible approach to the decision of this problem is the use of TrkA rec
Externí odkaz:
https://doaj.org/article/d43bd53c0b59490fbb19f06ff402785c
Актуальность. Одной из актуальных проблем, стоящих перед современной медицинской наукой, является изучение механизмов и поиск эффектив
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50607989c5271df177ea0f46cbd935ec
